Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

National Taiwan University Hospital

National Taiwan University Hospital in Taipei, Taiwan is listed as a site for 2,374 registered clinical trials, 692 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 2,374
Ongoing 692

This page covers the site record National Taiwan University Hospital in Taipei, Taiwan: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, National Taiwan University Hospital, also sponsors trials.

Get the National Taiwan University Hospital report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 2,374 trials counted.

  • Phase 1 140 trials
  • Phase 1/2 91 trials
  • Phase 2 273 trials
  • Phase 2/3 49 trials
  • Phase 3 539 trials
  • Phase 4 123 trials
  • Not applicable 501 trials
  • Observational 654 trials
  • Expanded access 4 trials

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 695 trials
  • Completed 895 trials
  • Terminated 181 trials
  • Other 603 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 170

1990: 1 trials (Observational 1) 1994: 1 trials (Observational 1) 1995: 2 trials (Not applicable 1, Phase 2 1) 1996: 3 trials (Observational 2, Not applicable 1) 1998: 2 trials (Observational 2) 1999: 4 trials (Observational 2, Phase 3 2) 2000: 1 trials (Not applicable 1) 2001: 5 trials (Observational 1, Not applicable 2, Phase 4 1, Phase 3 1) 2002: 13 trials (Observational 5, Not applicable 2, Phase 4 3, Phase 3 2, Phase 2 1) 2003: 22 trials (Observational 11, Not applicable 4, Phase 4 3, Phase 3 2, Phase 2/3 1, Phase 1 1) 2004: 43 trials (Observational 26, Not applicable 7, Phase 4 5, Phase 3 2, Phase 2 3) 2005: 68 trials (Observational 40, Not applicable 13, Phase 4 7, Phase 3 3, Phase 2/3 1, Phase 1/2 2, Phase 1 2) 2006: 42 trials (Observational 22, Not applicable 10, Phase 4 4, Phase 3 4, Phase 2/3 1, Phase 2 1) 2007: 60 trials (Observational 32, Not applicable 15, Phase 4 5, Phase 3 3, Phase 2 4, Phase 1 1) 2008: 58 trials (Observational 26, Not applicable 14, Phase 4 6, Phase 3 5, Phase 2/3 1, Phase 2 4, Phase 1/2 1, Phase 1 1) 2009: 63 trials (Observational 29, Not applicable 11, Phase 4 7, Phase 3 4, Phase 2 7, Phase 1/2 2, Phase 1 3) 2010: 71 trials (Observational 28, Not applicable 14, Phase 4 11, Phase 3 9, Phase 2 7, Phase 1 2) 2011: 73 trials (Observational 27, Not applicable 12, Phase 4 8, Phase 3 11, Phase 2 11, Phase 1 4) 2012: 60 trials (Observational 19, Not applicable 14, Phase 4 5, Phase 3 12, Phase 2/3 2, Phase 2 6, Phase 1/2 1, Phase 1 1) 2013: 56 trials (Observational 20, Not applicable 6, Phase 4 1, Phase 3 21, Phase 2 4, Phase 1/2 2, Phase 1 2) 2014: 90 trials (Observational 26, Not applicable 14, Phase 4 4, Phase 3 21, Phase 2/3 1, Phase 2 10, Phase 1/2 7, Phase 1 7) 2015: 81 trials (Observational 18, Not applicable 14, Phase 4 4, Phase 3 22, Phase 2/3 1, Phase 2 12, Phase 1/2 3, Phase 1 7) 2016: 83 trials (Observational 21, Not applicable 16, Phase 4 5, Phase 3 18, Phase 2/3 1, Phase 2 9, Phase 1/2 2, Phase 1 11) 2017: 120 trials (Observational 27, Not applicable 26, Phase 4 5, Phase 3 31, Phase 2/3 2, Phase 2 14, Phase 1/2 7, Phase 1 8) 2018: 144 trials (Observational 27, Not applicable 30, Phase 4 6, Phase 3 40, Phase 2/3 3, Phase 2 21, Phase 1/2 8, Phase 1 9) 2019: 156 trials (Observational 43, Not applicable 30, Phase 4 4, Phase 3 34, Phase 2/3 4, Phase 2 21, Phase 1/2 8, Phase 1 12) 2020: 159 trials (Observational 35, Not applicable 29, Phase 4 5, Phase 3 43, Phase 2/3 2, Phase 2 24, Phase 1/2 7, Phase 1 14) 2021: 151 trials (Observational 33, Not applicable 34, Phase 4 5, Phase 3 41, Phase 2/3 4, Phase 2 21, Phase 1/2 5, Phase 1 8) 2022: 170 trials (Observational 36, Not applicable 36, Phase 4 6, Phase 3 43, Phase 2/3 5, Phase 2 26, Phase 1/2 12, Phase 1 6) 2023: 156 trials (Observational 33, Not applicable 44, Phase 4 3, Phase 3 40, Phase 2/3 4, Phase 2 16, Phase 1/2 4, Phase 1 12) 2024: 157 trials (Observational 21, Not applicable 38, Phase 4 3, Phase 3 45, Phase 2/3 3, Phase 2 22, Phase 1/2 12, Phase 1 13) 2025: 160 trials (Observational 25, Not applicable 43, Phase 4 5, Phase 3 50, Phase 2/3 8, Phase 2 14, Phase 1/2 4, Phase 1 11)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 83
2025 160
2024 157
2023 156
2022 170
2021 151
2020 159
2019 156
2018 144
2017 120

2026 is partial: trials registered with a 2026 start date so far, not a full year. 1 trial is registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Conditions studied

The specific conditions of the trials that list this site, most trials first.